Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Non-Small-Cell Lung

Explore clinical trials studying Carcinoma, Non-Small-Cell Lung. Study availability and eligibility vary by location and protocol.

4,683 public trials 1,032 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Non-Small-Cell Lung trial results

Active, Not Recruiting

First in Human Study of AZD9592 in Solid Tumors

NCT05647122

Conditions
Advanced Solid Tumours, Bronchial Neoplasms, Carcinoma Non-small Cell Lung, +19 more
Locations
  • Research Site Duarte, California, United States
  • Research Site North Haven, Connecticut, United States
  • Research Site Washington D.C., District of Columbia, United States
  • Research Site Chicago, Illinois, United States
View all 46 locations
View Trial Details
Active, Not Recruiting

Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer

NCT04214262

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
Locations
  • Providence Alaska Medical Center Anchorage, Alaska, United States
  • NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro Jonesboro, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
View all 391 locations
View Trial Details
Active, Not Recruiting

Study to Allow Patients Previously Participating in a Novartis Sponsored Trial to Continue Receiving Capmatinib Treatment as Single Agent or in Combination With Other Treatments or the Combination Treatment Alone

NCT03040973

Conditions
Advanced Solid Tumors Which Are cMET-dependent, Bronchial Neoplasms, Carcinoma, Bronchogenic, +8 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Novartis Investigative Site Leuven, Belgium
  • Novartis Investigative Site Edmonton, Alberta, Canada
  • Novartis Investigative Site Shanghai, Shanghai Municipality, China
View all 15 locations
View Trial Details
Active, Not Recruiting

Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer

NCT03939481

Conditions
Adnexal Diseases, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, +66 more
Locations
  • Kaiser Permanente-Deer Valley Medical Center Antioch, California, United States
  • Kaiser Permanente Dublin Dublin, California, United States
  • Kaiser Permanente-Fremont Fremont, California, United States
  • Kaiser Permanente-Fresno Fresno, California, United States
View all 169 locations
View Trial Details
Active, Not Recruiting

Maintenance Chemotherapy With or Without Local Consolidative Therapy in Treating Patients With Stage IV Non-small Cell Lung Cancer

NCT03137771

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Arizona Center for Cancer Care - Gilbert Gilbert, Arizona, United States
  • Arizona Center for Cancer Care-Peoria Peoria, Arizona, United States
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
View all 301 locations
View Trial Details
Active, Not Recruiting

A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors

NCT05789069

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +45 more
Locations
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
  • New Experimental Therapeutics of Virginia - NEXT Oncology Fairfax, Virginia, United States
  • Istituto Nazionale Tumori IRCCS Fondazione G. Pascale Naples, Italy
View Trial Details

Related conditions